本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mangoceuticals, Inc.

2.49
-0.0800-3.11%
盘后2.40-0.0900-3.61%19:55 EDT
成交量:20.04万
成交额:52.70万
市值:1,287.03万
市盈率:-0.51
高:2.88
开:2.60
低:2.37
收:2.57
数据加载中...
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

SEC问询函

Form CORRESP - Correspondence
2024/05/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/11

重要事件披露

Form 8-K - Current report
2024/04/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/23

重要事件披露

Form 8-K - Current report
2024/01/02

重要事件披露

Form 8-K - Current report
2024/01/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]